Why the study?
Sex and gender discrepancies are under-reported in clinical trials, creating a consistent need for a precise reference of sex and gender issues in rheumatoid arthritis studies to improve treat-to-target achievement.
Design
Narrative review
Authors
Loading...
Should not yet alter RA management; leaves open prospective validation of sex-specific guidelines.
Sex and gender significantly influence disease course and treatment response in rheumatoid arthritis, necessitating their integration into clinical management guidelines.
Maranini et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: